These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 39075626)

  • 1. Cancer therapy-related cardiac dysfunction and the role of cardiovascular imaging: systemic review and opinion paper from the Working Group on Cardio-Oncology of the Korean Society of Cardiology.
    Cho I; You SC; Cha MJ; Hwang HJ; Cho EJ; Kim HJ; Park SM; Kim SE; Lee YG; Youn JC; Park CS; Shim CY; Chung WB; Sohn IS
    J Cardiovasc Imaging; 2024 Jul; 32(1):13. PubMed ID: 39075626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in Biomarkers for Detecting Early Cancer Treatment-Related Cardiac Dysfunction.
    Xiao H; Wang X; Li S; Liu Y; Cui Y; Deng X
    Front Cardiovasc Med; 2021; 8():753313. PubMed ID: 34859069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology.
    Pudil R; Mueller C; Čelutkienė J; Henriksen PA; Lenihan D; Dent S; Barac A; Stanway S; Moslehi J; Suter TM; Ky B; Štěrba M; Cardinale D; Cohen-Solal A; Tocchetti CG; Farmakis D; Bergler-Klein J; Anker MS; Von Haehling S; Belenkov Y; Iakobishvili Z; Maack C; Ciardiello F; Ruschitzka F; Coats AJS; Seferovic P; Lainscak M; Piepoli MF; Chioncel O; Bax J; Hulot JS; Skouri H; Hägler-Laube ES; Asteggiano R; Fernandez TL; de Boer RA; Lyon AR
    Eur J Heart Fail; 2020 Nov; 22(11):1966-1983. PubMed ID: 33006257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC).
    Čelutkienė J; Pudil R; López-Fernández T; Grapsa J; Nihoyannopoulos P; Bergler-Klein J; Cohen-Solal A; Farmakis D; Tocchetti CG; von Haehling S; Barberis V; Flachskampf FA; Čeponienė I; Haegler-Laube E; Suter T; Lapinskas T; Prasad S; de Boer RA; Wechalekar K; Anker MS; Iakobishvili Z; Bucciarelli-Ducci C; Schulz-Menger J; Cosyns B; Gaemperli O; Belenkov Y; Hulot JS; Galderisi M; Lancellotti P; Bax J; Marwick TH; Chioncel O; Jaarsma T; Mullens W; Piepoli M; Thum T; Heymans S; Mueller C; Moura B; Ruschitzka F; Zamorano JL; Rosano G; Coats AJS; Asteggiano R; Seferovic P; Edvardsen T; Lyon AR
    Eur J Heart Fail; 2020 Sep; 22(9):1504-1524. PubMed ID: 32621569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Overview of Cardio-Oncology, a New Frontier to Be Explored.
    Cheng KH; Wu YW; Hou CJ; Hung CM
    Acta Cardiol Sin; 2021 Sep; 37(5):457-463. PubMed ID: 34584378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardio-toxicity among patients with sarcoma: a cardio-oncology registry.
    Shamai S; Rozenbaum Z; Merimsky O; Derakhshesh M; Moshkovits Y; Arnold J; Topilsky Y; Arbel Y; Laufer-Perl M
    BMC Cancer; 2020 Jun; 20(1):609. PubMed ID: 32605637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling Precision Cardio-Oncology: Using Human-Induced Pluripotent Stem Cells for Risk Stratification and Prevention.
    Perry TR; Roberts ML; Sunkara B; Maddula R; McLeish T; Gomez J; Lucas J; Rayan D; Patel S; Liang M; Bosnjak ZJ; Brown SA
    Curr Oncol Rep; 2021 May; 23(7):77. PubMed ID: 33937943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society.
    Lyon AR; Dent S; Stanway S; Earl H; Brezden-Masley C; Cohen-Solal A; Tocchetti CG; Moslehi JJ; Groarke JD; Bergler-Klein J; Khoo V; Tan LL; Anker MS; von Haehling S; Maack C; Pudil R; Barac A; Thavendiranathan P; Ky B; Neilan TG; Belenkov Y; Rosen SD; Iakobishvili Z; Sverdlov AL; Hajjar LA; Macedo AVS; Manisty C; Ciardiello F; Farmakis D; de Boer RA; Skouri H; Suter TM; Cardinale D; Witteles RM; Fradley MG; Herrmann J; Cornell RF; Wechelaker A; Mauro MJ; Milojkovic D; de Lavallade H; Ruschitzka F; Coats AJS; Seferovic PM; Chioncel O; Thum T; Bauersachs J; Andres MS; Wright DJ; López-Fernández T; Plummer C; Lenihan D
    Eur J Heart Fail; 2020 Nov; 22(11):1945-1960. PubMed ID: 32463967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardio-Oncology: Managing Cardiovascular Complications of Cancer Therapies.
    Sharma R; Kashyap J; Olanrewaju OA; Jabbar A; Someshwar F; Saeed H; Varrassi G; Qadeer HA; Kumar S; Cheema AY; Khatri M; Wazir M; Ullah F
    Cureus; 2023 Dec; 15(12):e51038. PubMed ID: 38269231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardio-oncology in Austria: cardiotoxicity and surveillance of anti-cancer therapies : Position paper of the Heart Failure Working Group of the Austrian Society of Cardiology.
    Bergler-Klein J; Rainer PP; Wallner M; Zaruba MM; Dörler J; Böhmer A; Buchacher T; Frey M; Adlbrecht C; Bartsch R; Gyöngyösi M; Fürst UM
    Wien Klin Wochenschr; 2022 Sep; 134(17-18):654-674. PubMed ID: 35507087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical pharmacology of cardio-oncology: a novel interdisciplinary platform for basic and translational research].
    Sase K
    Nihon Yakurigaku Zasshi; 2020; 155(3):179-184. PubMed ID: 32378640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Australia and New Zealand Cardio-Oncology Registry: evaluation of chemotherapy-related cardiotoxicity in a national cohort of paediatric cancer patients.
    Lapirow D; La Gerche A; Toro C; Masango E; Costello B; Porello E; Ludlow L; Marshall G; Trahair T; Mateos M; Lewin J; Byrne J; Boutros R; Manudhane R; Heath J; Ayer J; Gabriel M; Walwyn T; Saundankar J; Forsey J; Le H; Mason K; Celermajer D; Downie P; Walker R; Holland L; Martin M; McLeman L; Diamond Y; Marcocci M; Donath S; Cheung M; Elliott DA; Conyers R
    Intern Med J; 2021 Feb; 51(2):229-234. PubMed ID: 31841257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardio-Oncology: mechanisms of cardiovascular toxicity.
    Markman TM; Markman M
    F1000Res; 2018; 7():113. PubMed ID: 29399333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction.
    Demissei BG; Hubbard RA; Zhang L; Smith AM; Sheline K; McDonald C; Narayan V; Domchek SM; DeMichele A; Shah P; Clark AS; Fox K; Matro J; Bradbury AR; Knollman H; Getz KD; Armenian SH; Januzzi JL; Tang WHW; Liu P; Ky B
    J Am Heart Assoc; 2020 Jan; 9(2):e014708. PubMed ID: 31959034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardio-oncology: management of cardiovascular toxicity.
    Markman TM; Markman M
    F1000Res; 2019; 8():. PubMed ID: 30755794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Cardio-Oncology Guideline - A Comprehensive Approach to Managing Cardiovascular Risks in Cancer Patients].
    Romann SW; Frey N; Lehmann L
    Dtsch Med Wochenschr; 2024 Jun; 149(12):719-723. PubMed ID: 38781996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation and acute cardiotoxicity in adult hematological patients treated with CAR-T cells: results from a pilot proof-of-concept study.
    Camilli M; Viscovo M; Felici T; Maggio L; Ballacci F; Carella G; Bonanni A; Lamendola P; Tinti L; Di Renzo A; Coarelli G; Galli E; Liuzzo G; Burzotta F; Montone RA; Sorà F; Sica S; Hohaus S; Lanza GA; Crea F; Lombardo A; Minotti G
    Cardiooncology; 2024 Mar; 10(1):18. PubMed ID: 38532515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Therapeutics-Related Cardiac Dysfunction　- Insights From Bench and Bedside of Onco-Cardiology.
    Kadowaki H; Akazawa H; Ishida J; Komuro I
    Circ J; 2020 Aug; 84(9):1446-1453. PubMed ID: 32727978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular adverse events and prognosis in patients with haematologic malignancies and breast cancer receiving anticancer agents: Kurume-CREO Registry insights.
    Shibata T; Nohara S; Morikawa N; Shibao K; Ito S; Shibata R; Toh U; Nagafuji K; Fukami K; Fukumoto Y
    Eur J Prev Cardiol; 2023 Dec; 30(18):1941-1949. PubMed ID: 37352112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Features of trastuzumab-related cardiac dysfunction: deformation analysis outside left ventricular global longitudinal strain.
    Nhat GM; Hai NH; Duc VT; Tri HHQ; Hoa CN
    Front Cardiovasc Med; 2024; 11():1291180. PubMed ID: 38312233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.